Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronocort vs Cortef in CAH
NCT00519818Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Aug 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone modified-release in congenital adrenal hyperplasia (CAH), sponsored by Neurocrine Biosciences. Started Aug 2007; status: completed.
02
Drugs
hydrocortisone modified-release
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT00519818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519818.